focus
Previous article:
Heart attack and stroke risk calculators need revising
Next article: Why Novartis is going to walk from its acquisition of MorphoSys
Next article: Why Novartis is going to walk from its acquisition of MorphoSys
hotspot
focus
-
Illumina slashes 2023 revenue projections yet again
2025-09-30 00:31 -
The Biogen Aduhelm mess could happen again
2025-09-29 23:54 -
Cano Health’s bankruptcy is a warning for Medicare Advantage
2025-09-29 23:31 -
Hospitals are dialing back on venture capital investing
2025-09-29 23:07 -
Texas Medical Board asked to define abortion emergency exception
2025-09-29 23:02 -
Megan Rapinoe shares emotional post following US Women's World Cup exit
2025-09-29 22:11